Short Summary
The petitioner filed a civil suit alleging infringement of Patent No. 124131, which covered a roasting apparatus. The respondent counterclaimed seeking revocation of the patent. The court examined whether the suits and counterclaims were premature because they were filed before the official sealing date of the patent.
Detailed Summary
This matter relates to a Patent dispute in Somabhai Ishwarbhai Bhagat v. Natwerlal Chhanalal And Co. And Ors. (Case No: 169364) before the Gujarat High Court decided on 1973-09-14.
The petitioner filed a civil suit alleging infringement of Patent No. 124131, which covered a roasting apparatus. The respondent counterclaimed seeking revocation of the patent. The court examined whether the suits and counterclaims were premature because they were filed before the official sealing date of the patent.
The court issued its ruling in accordance with statutory intellectual property guidelines and applicable legal principles, directing procedural or substantive relief based on the record presented.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Gujarat High Court. Understanding the court's reasoning in Somabhai Ishwarbhai Bhagat vs Natwerlal Chhanalal And Co. And Ors. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Kanishk SinhavsUnion Of India And Another
The petitioner filed a review application challenging an earlier order. The core issue was whether his implicit challenge to the constitutional validity (vires) of Section 53 of the Patents Act, 1970, had been overlooked during the original proceedings.
Usha International LimitedvsRegistrar Of Trademarks And Anr.
Usha International Limited filed a petition seeking the removal/cancellation of the mark 'WSHA' from the Trade Marks Register, arguing that it is deceptively similar to their long-standing mark 'USHA'. The Delhi High Court accepted the petition and issued notice to the respondents. The matter was subsequently listed for further arguments on April 4, 2022.
Msn Laboratories Pvt. LtdvsNovartis Ag
This appeal before the Telangana High Court concerned an infringement suit filed by Novartis Ag against Msn Laboratories Pvt. Ltd regarding patent IN 229051, which covers a specific Valsartan/Sacubitril combination drug. The respondents (Novartis) had secured an interim injunction based on prima facie evidence of infringement due to the appellant's (Msn Labs) manufacturing approval for a similar formulation. The court examined the statutory provisions of the Patents Act and CPC, ultimately dismissing the appeal and upholding the injunction granted in favor of Novartis.
Kawakami, Shigeki & Ors.vsAssistant Controller Of Patents And Designs
The appellants filed an appeal challenging the order dated November 15, 2021, passed by the Assistant Controller of Patents. The original application (No. 201817032492) was rejected on the ground of lack of novelty under Section 2(1)(j) of the Patents Act, 1970.
Vimala ParmarvsThe Deputy Registrar of Trademarks
The Madras High Court dismissed a Writ Petition filed by Vimala Parmar against The Deputy Registrar of Trademarks. The petitioner had sought judicial intervention to compel the Trademark Registry to accept evidence in an opposition proceeding concerning trademark application No. 812224. However, due to non-prosecution—the failure of the petitioner to file a new counsel or appear before the court—the High Court dismissed the petition.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.